Ascendis Pharma A/S (ASND) Stock Price Today
Aura AI Summary
Key Stats
- $18.08BMarket Cap
- -Volume
- HealthSector
- $277.1852W High
- $163.3252W Low
- -Typical Hold Time
- $18.45BEnterprise Value
- -Div Yield
- -Trading Activity
Track Ascendis Pharma A/S (ASND) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Ascendis Pharma A/S has traded between a low of $163.32 and a high of $277.18, highlighting its annual price range. Buy and sell Ascendis Pharma A/S shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Most Recent News
Global wax market to reach $16.65B by 2035 driven by packaging, cosmetics, and industrial demand.
The global wax market, valued at $11.26 billion in 2025, is projected to grow to $16.65 billion by 2035 at a CAGR of 3.99%. Growth is fueled by rising demand in packaging, cosmetics, candle making, adhesives, and industrial uses, with natural waxes l...

Basel Medical regains Nasdaq compliance after share price recovers above $1.00
Basel Medical Group Ltd announced it has regained compliance with Nasdaq's minimum bid price rule after its share price stayed at or above $1.00 for 10 consecutive business days ending July 7, 2026. The company was previously notified in January 2026...

Backpack launches first 24/7 market for real U.S. equities for global investors.
Backpack has introduced the first-ever 24/7 trading platform for real U.S. equities, allowing international investors to buy and sell stocks like SpaceX, Micron, and SanDisk around the clock. Unlike synthetic derivatives, these are actual equities wi...
